Authors: Lafaurie, M Perichon, B Lefort, A Carbon, C Courvalin, P Fantin, B

Citation: M. Lafaurie et al., Consequences of VanE-type resistance on efficacy of glycopeptides in vitroand in experimental endocarditis due to Enterococcus faecalis, ANTIM AG CH, 45(10), 2001, pp. 2826-2830

Authors: Perichon, B Courvalin, P

Citation: B. Perichon et P. Courvalin, Update on vancomycin resistance, INT J CL PR, 54(4), 2000, pp. 250-254

Authors: Perichon, B Courvalin, P

Citation: B. Perichon et P. Courvalin, Update on vancomycin resistance, INT J CL PR, 2000, pp. 88-93

Authors: Cavallo, JD Pean, Y Weber, P Allouch, P Bellon, O Cavallo, JD Chardon, H Chaslus-Dancla, E Dabernat, H Jarlier, V Martel, JL Marty, N Nicolas-Chanoine, MH Pean, Y Perichon, B Roussel-Delvallez, M Talon, D Weber, P

Citation: Jd. Cavallo et al., Factors influencing the frequency and the level of susceptibility of Escherichia coli and Proteus mirabilis strains to antibiotics, isolated from patients with urinary infections, in ambulatory treatment, MED MAL INF, 30(11), 2000, pp. 714-720

Authors: Perichon, B Casadewall, B Reynolds, P Courvalin, P

Citation: B. Perichon et al., Glycopeptide-resistant Enterococcus faecium BM4416 is a VanD-type strain with an impaired D-Alanine : D-Alanine ligase, ANTIM AG CH, 44(5), 2000, pp. 1346-1348

Authors: Fines, M Perichon, B Reynolds, P Sahm, DF Courvalin, P

Citation: M. Fines et al., VanE, a new type of acquired glycopeptide resistance in Enterococcus faecalis BM4405, ANTIM AG CH, 43(9), 1999, pp. 2161-2164